A detailed history of Integral Health Asset Management, LLC transactions in 89bio, Inc. stock. As of the latest transaction made, Integral Health Asset Management, LLC holds 500,000 shares of ETNB stock, worth $4.84 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
500,000
Previous 450,000 11.11%
Holding current value
$4.84 Million
Previous $3.6 Million 2.66%
% of portfolio
0.44%
Previous 0.35%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.36 - $9.66 $368,000 - $483,000
50,000 Added 11.11%
500,000 $3.7 Million
Q2 2024

Aug 14, 2024

BUY
$7.31 - $10.9 $1.1 Million - $1.64 Million
150,000 Added 50.0%
450,000 $3.6 Million
Q1 2024

May 15, 2024

BUY
$8.13 - $13.77 $2.44 Million - $4.13 Million
300,000 New
300,000 $3.49 Million

Others Institutions Holding ETNB

About 89bio, Inc.


  • Ticker ETNB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,484,500
  • Market Cap $450M
  • Description
  • 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...
More about ETNB
Track This Portfolio

Track Integral Health Asset Management, LLC Portfolio

Follow Integral Health Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integral Health Asset Management, LLC with notifications on news.